mRNA manufacturing and research continues to grow in Victoria
Manufacturer's Monthly
OCTOBER 6, 2022
The developers of the Pfizer/BioNTech COVID-19 mRNA vaccine have chosen Victoria to establish their Asia-Pacific mRNA clinical research and development centre which will form part of BioNTech’s global network. The new facility will support researchers to translate their work into medical breakthroughs. The state government has invested $1.3
119 
Let's personalize your content